Genae Girard of Lago Vista said she was ecstatic Thursday to hear that the U.S. Supreme Court had ruled that a company cannot own a person’s DNA.
Girard, 43, was one of six patients who sued Myriad Genetics of Salt Lake City over the company’s patenting of two genes associated with breast and ovarian cancer. The Supreme Court said that company can’t own naturally occurring genes but can patent synthetic strands of DNA created in a laboratory.
The story you're reading is premium content from the Austin American-Statesman. Subscribers get total access to all our in-depth news, digital editions and exclusive premium content. You can now also buy a 24-hour digital pass or 7-day digital pass.
For Subscribers: Sign in here if you have already registered your account.Sign In
For Subscribers: Register your account for digital access.Access Digital
Read MyStatesman.com now — 24-hour digital pass99¢ for 24-hours
Read MyStatesman.com all week — 7-day digital pass$3.99 for 7-days
Subscribe to the Statesman for as little as 33¢ per dayView Offers
CORRECTION: The cost of a breast cancer gene test by Ambry Genetics was incorrect in an earlier version of this story. The cost is $2,200.